Recent Advances in the Treatment of Alopecia Areata : Episode 3

Opinion

Video

April 3, 2023

Analyzing Phase 3 Clinical Trial Data of Baricitinib in Alopecia Areata

Author(s):

Raj Chovatiya, MD, PhD,George Han, MD, PhD

The expert panel discusses the secondary analysis from the phase 3 BRAVE clinical trials of baricitinib in alopecia areata.

EP: 1.Impact of Alopecia Areata on Quality of Life, and Current Standard of Treatment

EP: 2.JAK Inhibitor Baricitinib for Treatment of Alopecia Areata

EP: 3.Analyzing Phase 3 Clinical Trial Data of Baricitinib in Alopecia Areata

EP: 4.Novel Mechanisms of Action for Treatment of Alopecia Areata

EP: 5.Physician and Patient Communication for the Management of Alopecia Areata

Related Videos

Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch

Highlighting Recent Therapies for Dermatologists, with James Del Rosso, DO

James Del Rosso, DO: Discussing What’s New in the Medicine Chest for Dermatologists

What to Look Forward To at the Fall Clinical Dermatology Conference, with Raj Chovatiya, MD, PhD

Psoriasis podcast

Ashfaq Marghoob, MD: Artificial Intelligence, Smartphone Use for Pigmented Lesion Classification

Major Diagnostic Challenges for Pigmented Lesions, with Ashfaq Marghoob, MD

Discussing Interim Findings on Nemolizumab for Atopic Dermatitis, with Diamant Thaçi, MD

Responding to FDA Approval of Lebrikizumab for Atopic Dermatitis, with Andrew Alexis, MD, MPH

3 KOLs are featured in this series.

Related Content

Related Content

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.